Baird Financial Group
WST icon

Baird Financial Group’s West Pharmaceutical WST Stock Holding History

Baird Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8M Sell
46,908
-10,379
-18% -$3.17M 0.02% 452
2026
Q1 		$14.4M Sell
57,287
-88,919
-61% -$22.1M 0.02% 457
2025
Q4 		$40.2M Buy
146,206
+24,603
+20% +$6.73M 0.06% 204
2025
Q3 		$31.9M Sell
121,603
-32,226
-21% -$7.83M 0.05% 265
2025
Q2 		$33.7M Sell
153,829
-11,893
-7% -$2.54M 0.06% 253
2025
Q1 		$37.1M Buy
165,722
+163,502
+7,365% +$45.1M 0.07% 226
2024
Q4 		$727K Buy
2,220
+188
+9% +$59.2K ﹤0.01% 1271
2024
Q3 		$610K Buy
2,032
+664
+49% +$203K ﹤0.01% 1311
2024
Q2 		$451K Sell
1,368
-128
-9% -$45.2K ﹤0.01% 1430
2024
Q1 		$592K Buy
1,496
+925
+162% +$342K ﹤0.01% 1326
2023
Q4 		$201K Sell
571
-418
-42% -$148K ﹤0.01% 1643
2023
Q3 		$371K Sell
989
-2,636
-73% -$1.02M ﹤0.01% 1442
2023
Q2 		$1.39M Buy
3,625
+2,169
+149% +$775K ﹤0.01% 1012
2023
Q1 		$504K Sell
1,456
-7,237
-83% -$2.11M ﹤0.01% 1314
2022
Q4 		$2.04M Buy
8,693
+998
+13% +$236K 0.01% 865
2022
Q3 		$1.89M Buy
7,695
+1,541
+25% +$469K 0.01% 851
2022
Q2 		$1.86M Buy
6,154
+1,892
+44% +$616K 0.01% 874
2022
Q1 		$1.75M Buy
4,262
+2,576
+153% +$1.01M ﹤0.01% 954
2021
Q4 		$791K Sell
1,686
-7
-0.4% -$3.01K ﹤0.01% 1290
2021
Q3 		$719K Buy
1,693
+461
+37% +$194K ﹤0.01% 1336
2021
Q2 		$442K Buy
+1,232
New +$407K ﹤0.01% 1439
2021
Q1 		– Sell
-1,332
Closed -$377K – 1734
2020
Q4 		$377K Buy
+1,332
New +$374K ﹤0.01% 1303

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Baird Financial Group's WST Position: Q2 2026 in Review

Baird Financial Group reduced its West Pharmaceutical (WST) stake by 18% in Q2 2026, selling an estimated $3.17M and leaving 46,908 shares worth $16.8M. The position accounts for 0.02% of the portfolio, ranked #452.

Baird Financial Group first reported a position in WST in Q4 2020 and has held it in 22 quarters since. The position peaked at $40.2M in Q4 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Baird Financial Group held 46,908 shares of West Pharmaceutical worth $16.8M as of Q2 2026.
  • Baird Financial Group sold 10,379 West Pharmaceutical shares in Q2 2026, an estimated $3.17M.
  • West Pharmaceutical made up 0.02% of Baird Financial Group's portfolio in Q2 2026, its #452 holding.
  • Baird Financial Group first reported a position in West Pharmaceutical in Q4 2020 and has held it in 22 quarters since.
  • Baird Financial Group's West Pharmaceutical position peaked at $40.2M in Q4 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.